Vivos Demonstrates that IsoPet™ (RadioGel™) is effective in killing cancer in cats   Richland, WA, May 01, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) announced today the results from the therapy for feline sarcoma.     Five cats were treated at Washington...

Vivos Adds Commercial Expertise to its Veterinary Medicine Advisory Board Richland, WA, March 20, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) announced today that it added a new member on the Veterinary Medicine Advisory Board.    Tariq Shah BSc. DipMS is the...

Vivos Receives FDA Confirmation of RadioGel Device Classification for Animal Skin Cancer Therapy Richland, WA, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) announced today that it has been notified by the   FDA that RadioGel™ is classified as a device for animal therapy. ...

Vivos Completes Planned Dosing Schedule for Feline Sarcoma Program Richland, WA, Jan. 12, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) announced today that it has completed its planned dosing schedule to determine the effectiveness of using the Company’s...

Advanced Medical Isotope Corporation (ADMD) Announces Corporate Name Change to Vivos Inc., and Ticker Symbol Change to RDGL Richland, WA, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Advanced Medical Isotope Corporation (OTCPink: RDGL) announced today that it has changed its name to Vivos Inc., and that its shares are scheduled to...